Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma - Mai, Elias K.; Raab, Marc-Steffen; Neben, Kai; Goldschmidt, Hartmut; Bertsch, Uta; Jauch, Anna; Schurich, Bärbel; Merz, Maximilian; Hügle-Dörr, Barbara; Seckinger, Anja; Hose, Dirk; Hillengaß, Jens (Leukemia, 2015)
Gesehen am 24.04.2015